OTC Markets · Medical Devices · USD
STRATA Skin Sciences, Inc. (SSKN) Stock Analysis
STRATA Skin Sciences, Inc. (SSKN) is a Medical Devices stock listed on OTC Markets and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
SSKN Key Statistics
As of Sep 4, 2026Trading
- Open
- $0.00
- Previous Close
- $0.01
- Volume
- 175
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.03
Valuation
- Market Cap
- $29.44K
- P/E Ratio
- unprofitable
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.03
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −1.35
Financials (FY)
- Revenue (FY)
- $30.70M−8.54%
- Net Income (FY)
- −$6.26M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −20.40%
- Shares Outstanding
- 5.89M
- 1-Year Return
- −99.99%
Dividend and dates
- Avg Volume
- 4.84K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
SSKN Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −99.98% |
| 2025 | −56.70% |
| 2024 | +428.99% |
| 2023 | −30.38% |
| 2022 | −46.07% |
| 2021 | −2.33% |
| 2020 | −27.88% |
| 2019 | −20.00% |
| 2018 | +111.38% |
| 2017 | −44.09% |
| 2016 (partial year) | −31.27% |
As of September 4, 2026.
SSKN Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $30.70M | −$6.26M | −20.4% |
| 2024 | $33.56M | −$10.09M | −30.1% |
| 2023 | $33.36M | −$10.83M | −32.5% |
| 2022 | $36.16M | −$5.55M | −15.3% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $30.70M | $17.88M | −$5.84M | −$6.26M | −20.4% |
| 2024 | $33.56M | $19.22M | −$4.99M | −$10.09M | −30.1% |
| 2023 | $33.36M | $18.46M | −$6.32M | −$10.83M | −32.5% |
| 2022 | $36.16M | $21.77M | −$4.65M | −$5.55M | −15.3% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
SSKN Valuation vs Medical Devices Median
Median of 151 stocks| Metric | SSKN | Medical Devices median | vs median |
|---|---|---|---|
| P/S ratio | 0.00 | 2.98 | 0.0x the median |
| Profit margin | −20.40% | −1.69% | 18.7 pts below |
Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Devices Stocks
Abbott Laboratories
$187.45B
MDTMedtronic plc.
$120.46B
SYKStryker Corporation
$116.27B
BSXBoston Scientific Corporation
$69.27B
EWEdwards Lifesciences Corporation
$51.82B
DXCMDexCom, Inc.
$33.17B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B